title: Diagnostic challenges in a case of B cell lymphoma unclassifiable with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
abstract: Unclassifiable B-cell lymphoma with features intermediate between diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma (BL) is a recently recognized category of mature B-cell lymphoma. This represents a heterogeneous group of diseases which often pose diagnostic problems in clinical practice, yet its distinction from DLBCL to BL is important for its therapeutic and prognostic implications. We report the challenging diagnostic process of a 60-year-old man. He had a CD10 and BCL2-positive, BCL6-negative B-cell malignancy with loss of multiple B-cell markers including surface immunoglobulin. The karyotype was complex and unusual, including t(2;18)(p12;q21), t(8;14)(q24;q32) and a derivative chromosome 22 mimicking a Philadelphia chromosome that led to initial diagnostic confusion. A triple-hit gray zone B-cell lymphoma with rearrangements of MYC, BCL2, BCL6, both alleles of IGH and likely IGK and IGL was finally diagnosed upon additional fluorescence in situ hybridization (FISH) studies. His disease was nonresponsive to intensive combination chemotherapy and he died 4 months after presentation. This case illustrates the diagnostic difficulty encountered in such group of B-cell lymphomas and emphasizes the need to integrate morphological, immunophenotypic and genetic data in making a diagnosis.
authors: Chi-Chiu
authors: CC
authors: So
authors: Ka-Hung
authors: KH
authors: Yung
authors: Man-Leng
authors: ML
authors: Chu
authors: Thomas S K
authors: TS
authors: Wan
mesh_terms: D001853:Bone Marrow / Q000473:pathology; D002051:Burkitt Lymphoma / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D003937:Diagnosis, Differential; D017809:Fatal Outcome; D006801:Humans; D016130:Immunophenotyping; D017404:In Situ Hybridization, Fluorescence; D059785:Karyotype; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010641:Phenotype
references: Leuk Res. 2003 Jun;27(6):561-6
references: 12648517
references: Br J Haematol. 2009 Mar;144(5):716-25
references: 19120369
references: N Engl J Med. 2006 Jun 8;354(23):2431-42
references: 16760443
references: N Engl J Med. 2006 Jun 8;354(23):2419-30
references: 16760442
references: J Clin Oncol. 2011 May 10;29(14):1835-43
references: 21482997
references: Blood. 1983 Nov;62(5):1142-6
references: 6605167
references: Leukemia. 1999 Jan;13(1):135-41
references: 10049049
references: Curr Oncol Rep. 2012 Oct;14(5):387-94
references: 22669492
references: Proc Natl Acad Sci U S A. 1984 Nov;81(22):7166-70
references: 6334305
references: Br J Haematol. 2013 Jul;162(1):40-9
references: 23600716
references: Haematologica. 2009 Jul;94(7):894-6
references: 19570750